Structural and Biochemical Basis of the Vitamin K cycle
Structural and Biochemical Basis of the Vitamin K cycle
批准号:
7714059
负责人:
Weikai Li
金额:
$9.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2011-07-31
关键词:
AcidsAddressAllergensAmino AcidsAnimalsAnticoagulantsAreaAsthmaAwardBindingBiochemicalBioinformaticsBiological AssayBlood Coagulation FactorBlood VesselsBreathingCalcium ionCatalysisChronicComplexCoumarinsCoupledCouplesCulture TechniquesCysteineDeep Vein ThrombosisDendritic CellsDiseaseElectron TransportElectronsEnzymesEpithelialEpithelial CellsEpitheliumFutureGeneticGenetic Predisposition to DiseaseGoalsHemorrhageHigh Pressure Liquid ChromatographyHomologous GeneHumanHydroquinonesInbred Strains MiceInflammatoryLaboratoriesLeadLungLung diseasesMapsMediatingMedicalMembraneMembrane ProteinsMentorsMethodsModelingMolecular ConformationMusMutagenesisMutationMyelogenousMyocardial InfarctionOralPancreatic ribonucleasePathologyPathway interactionsPeptidesPeriplasmic ProteinsPharmaceutical PreparationsPhasePopulationPrincipal InvestigatorProductionProtein Disulfide IsomeraseProtein translocationProteinsPublishingPulmonary EmbolismQuinonesReactionRecombinantsResearchResearch PersonnelResolutionRoleScientistSeriesStagingStrokeStructureSurfaceSusceptibility GeneSynechococcusT-LymphocyteTh2 CellsTherapeuticThioredoxinThrombosisTrainingUniversitiesVitamin KVitaminsWarfarinWorkairway hyperresponsivenessalpha benzopyronebasecarboxylationcareercareer developmentcofactorcytokinedensitydesigndrug mechanismelectron densityelectron donorepoxidasegamma-glutamyl carboxylasehigh riskhydroquinoneimprovedinhibitor/antagonistmutantnovelperiplasmpreventreduced vitamin Kresearch studyresistance mutationresponsesample fixationskillstoolvitamin K epoxide reductasevitamin K1 oxide
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Asthma is a chronic inflammatory disease of the lung thought to be mediated exclusively by the products of Th2 cells. Preliminary evidence suggests that genetic susceptibility to allergen-induced airway hyperresponsiveness (AHR) results from differential epithelial cell responsiveness to inhaled allergen. In susceptible animals, epithelial cell-derived factors selectively enhance the activation, and production of Th17-skewing cytokines by pulmonary myeloid dendritic cells (mDC). However, it is unclear how the epithelium enhances mDC capacity to promote Th17 responses, or how Th17 and Th2 cells collaborate to exacerbate asthma. The aims are: 1) to identify the epithelial cell factors responsible for promoting the activation of pulmonary mDCs, 2) identify the role of Th17 responses in exacerbating the Th2-associated pathology, and 3) identify novel asthma susceptibility genes using a novel tool, recombinant inbred mouse strains from the Collaborative Cross. The studies and career development activities outlined in this proposal will allow the candidate to achieve his long term career goal of becoming an independent investigator with a focus on dissecting how genetic differences influence the ability of epithelial cells to regulate dendritic cell activity, and promote Th17 T cell responses. To acquire the necessary skill set, the candidate's K99 research will take place in the lab of Marsha Wills-Karp, an expert in the field of asthma genetics, and pulmonary epithelial culture techniques, where he will acquire expertise in the culture and manipulation of
murine pulmonary epithelium. Moreover, during the mentored phase, the candidate will acquire expertise in the use of genetic and bioinformatics approaches to identify novel asthma susceptibility genes, through advanced training at the University of Cincinnati, and Jackson Laboratories. This training will be essential for completing the research proposed for the independent phase of this award. Subsequent studies to dissect the function of identified asthma susceptibility genes in murine and human populations will form the basis of future R01 applications, assisting in the transition to scientific independence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the partner interaction network of the tetraspanin CD53 in regulating B cell trafficking
-
批准号:10660927
-
项目类别:
-
资助金额:$56.53万
-
财政年份:2022
-
负责人:Weikai Li
-
依托单位:
Defining the partner interaction network of the tetraspanin CD53 in regulating B cell trafficking
-
批准号:10364239
-
项目类别:
-
资助金额:$57.26万
-
财政年份:2022
-
负责人:Weikai Li
-
依托单位:
Structural and Functional Basis of the Vitamin K Cycle
-
批准号:10163694
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2014
-
负责人:Weikai Li
-
依托单位:
STRUCTURAL AND FUNCTIONAL BASIS OF THE VITAMIN K CYCLE
-
批准号:9047306
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2014
-
负责人:Weikai Li
-
依托单位:
Structural and Functional Basis of the Vitamin K Cycle
-
批准号:10400676
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2014
-
负责人:Weikai Li
-
依托单位:
Structural and Biochemical Basis of the Vitamin K cycle
-
批准号:8166297
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2011
-
负责人:Weikai Li
-
依托单位:
Structural and Biochemical Basis of the Vitamin K cycle
-
批准号:8228021
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2011
-
负责人:Weikai Li
-
依托单位:
Structural and Biochemical Basis of the Vitamin K cycle
-
批准号:8438455
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2011
-
负责人:Weikai Li
-
依托单位:
海外基金